Latest Regenerative Cardiovascular News

Subscribe

Longeveron Nabs Patent for Stem Cell Testing Techniques in Japan

With the right secured for stem cell potency, Longeveron is continuing its path forward with clinical trials for several mesenchymal stem cell indications.

Cellistic Unveils New Induced Pluripotent Stem Cell Manufacturing Platforms for Cancer and Regenerative Therapies

The new platforms aim to streamline large-scale production of iPSC-derived cell therapies for new indications.

Mayo Clinic Develops Stem Cell Patch to Potentially Repair Heart Damage Without Surgery

Researchers are testing a minimally invasive stem cell patch that could reduce the need for transplants.

Potential Retraction Coming on Pivotal Phase 3 Stem Cell Trial for Heart Failure

What appeared to be a potential stem cell breakthrough is slowly being torn apart by peer-reviewers, who found damning inconsistencies in the data.

Celularity Reports Phase 2 Trial Results on Placenta-Derived Cell Therapy for Diabetic Foot Ulcers with Peripheral Artery Disease

The Phase 2 study showed good results for placenta-derived cell therapy for diabetic foot ulcers complicated by PAD.

RoosterBio Helping Secretome Therapeutics Scale Cardiac Cell Therapy Manufacturing

RoosterBio and Secretome advance scalable cell therapy manufacturing with a new 50L bioreactor process for STM-01 clinical trials.

Capricor Therapeutics Announces FDA Type A Meeting to Discuss Duchenne Muscular Dystrophy Treatment Path

Capricor Therapeutics is coordinating with the FDA on regulatory steps for its Duchenne therapy, with updates expected soon.

New Trial: Mesenchymal Stem Cell Exosomes for Preventing and Treating Organ Failure After Aortic Dissection Surgery

Researchers in China are testing whether exosomes can help prevent or treat organ failure after aortic dissection surgery.

Longeveron Licenses Stem Cells from the University of Miami for Heart Disease

The technology aims to generate safer heart muscle cells for cardiovascular disease therapies and research.

New Trial: iPSC-Derived Exosome Therapy for Moyamoya Disease

Researchers are testing whether exosomes from stem cells can enhance blood vessel repair for Moyamoya patients after surgery.
Load More
x
Subscribe
Subscribe

Stay updated on Regenerative Medicine

Subscribe